immunomodulators


Also found in: Dictionary.

immunomodulators

Drugs that can act on the immune system in a therapeutically helpful manner. They include INTERFERONS and glatiramer acetate (Copaxone) for multiple sclerosis; tacrolimus (Protopic) and pimecrolimus (Elidel) for severe atopic eczema; and inosine pranobex (Imunovir) for herpes simplex infections.
References in periodicals archive ?
About Immodulon Immodulon Therapeutics Ltd is a privately owned, UK-based biopharmaceutical company focused on developing systemic immunomodulators as potential treatments for a range of cancers.
Contract award: bead20140212 immunomodulators for 2015.
Treatment of patients with inflammatory bowel disease with the immunomodulators azathioprine or 6-mercaptopurine is associated with about a fourfold increased risk of lymphoma, reported A.
1) Among the many treatments for CIDP are plasmapheresis, intravenous immunoglobulin (IV Ig), corticosteroids, and other immunomodulators such as azathioprine, cyclosporine, and cyclophosphamide.
SciClone has exclusive worldwide rights outside of Russia to SCV-07 and other compounds of a new class of immunomodulators from Verta.
Physicians typically limit steroid use and try to taper patients off the drugs while using immunomodulators, which control inflammation, but may take several months to become effective.
Given that interferons are known immunomodulators, I do not want any of us to have to wait for a retrospective study that may show these drugs to be a risk factor for cervical dysplasia.
Immunomodulators undergoing trails include interleukin-2.
com/research/0851d3/the_immunomodulato) has announced the addition of the "The Immunomodulators Market Outlook to 2016" report to their offering.
This expansion of our drug discovery programs is expected to provide additional, novel immunomodulators for future treatment of cancer patients.
Entyvio is approved to treat those conditions when one or more standard therapies (corticosteroids, immunomodulators, or tumor necrosis factor blocker medications) have not resulted in an adequate response.
Studies suggest that the proportion of patients responding to a single dose of infliximab is higher among those also receiving immunomodulators, Dr.